Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PRAA | ECPG |
|---|---|---|
| Price | $20.28 | $99.27 |
| Change today | ▲ 1.20% | ▲ 0.08% |
| Market cap | $763.50M | $2.11B |
| Return, 3 months | +11.0% | +8.1% |
| Return, year to date | +14.6% | +82.6% |
| Return, 1 year | +45.5% | +132.6% |
| P/E (TTM) | -3.0 | 7.5 |
| P/B | 0.7 | 2.0 |
| P/E percentile vs own 5y | 21st | 86th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +29.1% | +11.3% |
| Net profit growth (YoY) | +28.9% | +9.0% |
| Gross margin | 67.8% | 55.4% |
| Operating margin | 25.8% | 37.7% |
| Net margin | -19.7% | 15.9% |
| Return on equity | -22.3% | 30.5% |
| Analyst target vs. price | +28.2% | +16.9% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 57 | 55 |
| 30-day volatility | 31.9% | 30.3% |
| Max drawdown, 1 year | -42.3% | -10.3% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
